|
The study may not
continue after the approval period without additional IRB
review and approval for continuation. You will receive an email
renewal reminder notice prior to study expiration; however, it
is your responsibility to assure that this study is not
conducted beyond the expiration date.
Please be
aware that only IRB-approved informed consent forms may be used
when informed consent is required.
Any changes to
the protocol or informed consent must be reviewed and approved
prior to implementation unless the change is necessary for the
safety of subjects. In addition, you must inform the IRB of
serious adverse events encountered during the course of the
study or of any new and significant information that might
impact a research participant's safety or willingness to
continue in your study.
Investigators are required
to ensure that all HIPAA requirements have been met prior to
initiating this study. Once approved, validated HIPAA forms may
be found within INSPIR as External Attachments.
Please
note that the IRB is no longer stamping attachments, subject
letters, recruitment materials, etc. These documents are each
associated with this approved version of the protocol. They can
be found by going to Letters/Protocol History in INSPIR and
clicking on the highlighted (linked) word "Approved"
and then clicking on the paperclip icon in the upper left
corner.
|